silicon carbide has been researched along with Coronary Restenosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biering-Sørensen, T; Bjerking, LH; Galatius, S; Hansen, KW; Jeger, R; Kaiser, C; Pfisterer, M; Sørensen, R | 1 |
| Bosmans, JM; Claeys, MJ; Cornez, BM; Haine, SE; Jacobs, JM; Miljoen, HP; Vandendriessche, TR; Vrints, CJ | 1 |
| Becker, J; Dahm, JB; Nordbeck, H; Ruppert, J; Willems, T; Wolpers, HG | 1 |
| Deleanu, D; Dorobantu, M; Hamon, M; Niculescu, R; Waksman, R; Weissman, NJ | 1 |
| Hamm, CW; Hugenholtz, PG | 1 |
| Abizaid, A; Albertal, M; Feres, F; Mattos, LA; Paula, JE; Pinto, IM; Sousa, AG; Sousa, JE; Staico, R; Tanajura, LF | 1 |
| Lowe, R; Menown, IB; Nogareda, G; Penn, IM | 1 |
1 review(s) available for silicon carbide and Coronary Restenosis
| Article | Year |
|---|---|
Coronary stents: in these days of climate change should all stents wear coats?
Topics: Carbon; Carbon Compounds, Inorganic; Chromium Alloys; Coronary Restenosis; Heparin; Humans; Metals; Phosphorylcholine; Silicon Compounds; Stents; Tantalum | 2005 |
2 trial(s) available for silicon carbide and Coronary Restenosis
| Article | Year |
|---|---|
Silicon carbide-coated stents in patients with acute coronary syndrome.
Topics: Acute Disease; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Biomarkers; Blood Vessel Prosthesis Implantation; Carbon Compounds, Inorganic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Disease; Coronary Restenosis; Electrocardiography; Endpoint Determination; Equipment Design; Female; Follow-Up Studies; Humans; Male; Middle Aged; Postoperative Complications; Risk Factors; Severity of Illness Index; Silicon Compounds; Stents; Syndrome; Treatment Outcome; Troponin | 2003 |
[Randomized intravascular ultrasound comparison between endoprostheses with and without amorphous silicon-carbide].
Topics: Biocompatible Materials; Carbon Compounds, Inorganic; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Humans; Hyperplasia; Male; Middle Aged; Prospective Studies; Silicon Compounds; Stents; Treatment Outcome; Tunica Intima; Ultrasonography | 2004 |
4 other study(ies) available for silicon carbide and Coronary Restenosis
| Article | Year |
|---|---|
Do ultrathin strut bare-metal stents with passive coating improve efficacy in large coronary arteries? Insights from the randomized, multicenter BASKET-PROVE trials.
Topics: Aged; Carbon Compounds, Inorganic; Chromium Alloys; Coronary Artery Disease; Coronary Restenosis; Female; Humans; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Percutaneous Coronary Intervention; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Silicon Compounds; Stents; Time Factors; Treatment Outcome | 2019 |
Difference in clinical target lesion revascularization between a silicon carbide-coated and an uncoated thin strut bare-metal stent: the PRO-Vision study.
Topics: Aged; Carbon Compounds, Inorganic; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Silicon Compounds; Stents; Treatment Outcome | 2013 |
Clinical investigation into the observation that silicon carbide coating on cobalt chromium stents leads to early differentiating functional endothelial layer, increased safety and DES-like recurrent stenosis rates: results of the PRO-Heal Registry (PRO-K
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Carbon Compounds, Inorganic; Cell Proliferation; Chromium Alloys; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Silicon Compounds; Stents; Time Factors; Treatment Outcome | 2009 |
Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study.
Topics: Aged; Carbon Compounds, Inorganic; Chromium Alloys; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Hyperplasia; Incidence; Male; Middle Aged; Myocardial Infarction; Neointima; Percutaneous Coronary Intervention; Prospective Studies; Silicon Compounds; Sirolimus; Treatment Outcome | 2013 |